Laurus Labs Limited

LAURUSLABS.NS·NSE·Healthcare
Compare
2,022.50−46.50 (−2.25%)today
As of Oct 21, 12:00 PM IST · May be delayed up to 15 min · INR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close2,069.00
Open2,052.90
Day range2,022.502,079.80
52-week range902.352,089.00
Off day high−2.76%
Off 52-week high−3.18%
Volume530.23K
Avg. volume (3M)2.43M
Market cap1.09T
EPS (TTM)20.23
Forward P/E67.43
P/E ratio (TTM)99.98
Dividend yield0.12% (2.40)
Beta (5Y)0.34
Shares outstanding540.31M
Short interest—
Earnings dateOct 29, 2026
Analyst target1,703.07
Profit margin15.04%

Against its peers

Compare in full ›
LAURUSLABS.NS AUROPHARMA.BO LUPIN.NS ALKEM.NS IPCALAB.BO ZYDUSLIFE.BO
Market cap 1.09T 916.88B 898.12B 599.62B 486.30B 1.11T
P/E (TTM) 100.0 26.8 16.3 27.8 37.1 24.9
Forward P/E 67.4 21.0 19.4 22.4 27.2 22.7
Price/book 20.6 2.6 4.0 4.3 6.0 4.1
Dividend yield 0.12% 0.33% 0.93% 0.40% 0.33% 0.09%
1-year change +123.94% +1.70% −0.16% −9.58% +42.49% +10.44%
Today −2.25% −2.40% +1.28% +0.22% +5.60% +0.39%

The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.

Free Press Journal·Positive

Laurus Labs Invests ₹107.8 Crore In KRKA Pharma, Maintains 49% Stake

Mumbai: Laurus Labs Limited has invested ₹107.8 crore in KRKA Pharma Private Limited through a rights issue, according to a company announcement dated October 14, 2026. The pharmaceutical company acquired 10.78 crore equity shares with a…

The Times of India·Positive

Laurus Labs invests $11.3 million in KRKA Pharma JV

The Times of India Hyderabad: Pharma major Laurus Labs has invested around Rs 108 crore ($11.3 million) in KRKA Pharma Private Limited, its Hyderabad-based joint venture with Slovenia’s KRKA, through a rights issue, the company said in a…

Business Upturn·Positive

Laurus Labs receives ESG rating of 82.6 from CARE ESG Ratings

Laurus Labs Limited has been assigned an ESG rating of 82.6 by CARE ESG Ratings Limited, indicating a leadership position in managing ESG risks. Laurus Labs receives ESG rating of 82.6 from CARE ESG Ratings Laurus Labs Limited has been…

Kalkine India·Positive

Laurus Labs LAURUSLABS Reg 74(5) Certificate Q2 FY27

Kalkine India Laurus Labs (NSE:LAURUSLABS): Has It Filed Its Q2 FY27 Depository Compliance Certificate? Source: Krish Capital Pty Ltd Laurus Labs Limited (NSE:LAURUSLABS) submitted its Regulation 74(5) compliance certificate to NSE and BSE…

From articles in the 4Search news index.

In the news

14mentions in 30 days
14with it in the headline
Positivesentiment

Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 14 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use.